The president and CEO of Emergent BioSolutions, the Johnson & Johnson COVID-19 vaccine manufacturer, sold more than $10 million worth of stocks before millions of doses of the vaccine were ruined at a Baltimore facility. According to the Post, Robert G. Kramer sold off shares of the company in late …
Read More »